Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10266-10272
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10266
Table 1 Review of clinical characteristics, management, and outcome of coronary artery aneurysm caused by Kawasaki Disease in the case report
Ref.
Age (yr)
Sex
Indication
Sites
Sizes
FU
Operation
Antithrombotic therapy
Adjuvant drug
Outcome
Hu et al[8], 20148MaleRuptured coronary aneurysmLAD/RCA3.7 mm/5.2 mm12 dNOASAIVIG (2 g/kg), ramiprilDead
Sato et al[9], 201435MaleAMILAD2.3 mm × 2.0 mm9 yrPCINONOStable
Matsushita et al[10], 201432MaleAMILAD/RCANA30 yrPCIASANOStable
Ekici et al[11], 20144 moNAMILAD/RCA6.5 mm/6.7 mm51 dNOASA, LMWHIVIG (2 g/kg), acetylsalicylic acidDead
Luu et al[12], 201517MaleMILAD/LCX/RCANA18 moPCIASA, clopidogrelBisoprolol, ramiprilStable
Chong et al[13], 20189FemaleSevere respiratory failureLAD7 mm8 moNOASA, Enoxaparin, warfarinIVIG (2 g/kg)Stable
Takai et al[14], 20193MaleFeverRCA8.3 mm3 moNOASA, ticlopidine, warfarin,IVIG (2 g/kg), urinastatin, infliximab, enalaprilStable
Tsuda et al[15], 202058FemalePalpitateLADNANAImplantable defibrillator, Implantation, radiofrequency catheter ablationASABeta-blocker, verapamilStable
Chen et al[16], 202022MaleAMILMCA18 - 20 mm2 moHeart transplantRivaroxaban, clopidogrelMetoprolol, rosuvastatin, spironolactoneStable
Fujioka et al[17], 202133FemalePostpartumRCA25 mm5 moResection, CABGASA, ticlopidine hydrochlorideNAStable
Wang et al[18], 20215 moMaleCerebral infarctionLAD/RCA11 mm × 9 mm/19 mm × 14 mm15 moNAASA, clopidogrelIVIG (2 g/kg)Dead
Almeshary et al[19], 20214 moNAFeverLMCA/LAD/RCA4.6 mm/3.8 mm/4.2 mm1 moNAASAIVIG (2 g/kg)Stable
Toyoshima et al[20], 202214FemaleAMILMCA/LAD7.2 mm/4.0 mm1 yrCABGwarfarin, clopidogrelCarvedilol, enalaprilStable